CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −13,473 | $16.58 | $223K | 38,174 |
| 2026-05-05 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −582 | $17.18 | $10K | 37,592 |
| 2026-05-04 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −8,148 | $16.96 | $138K | 18,305 |
| 2026-05-01 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −5,394 | $16.76 | $90K | 26,453 |
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,000 | 47,427 | ||
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise | +3,750 | 51,177 | ||
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,858 | 54,035 | ||
| 2026-04-30 | van Houte Hans Chief Financial Officer | Sale | −2,388 | $16.65 | $40K | 51,647 |
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 0 | ||
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −3,750 | 15,000 | ||
| 2026-04-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,858 | 22,867 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise | +2,000 | 28,453 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise | +3,750 | 32,203 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise | +2,858 | 35,061 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Sale | −3,214 | $16.65 | $53K | 31,847 |
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,000 | 0 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −3,750 | 15,000 | ||
| 2026-04-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,858 | 22,867 | ||
| 2026-04-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +2,000 | 117,005 | ||
| 2026-04-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,750 | 120,755 |
Page 6 of 20 · 381 trades